COVID-19 Vaccines and Herd Immunity

COVID-19 Vaccines and Herd Immunity

In the case of COVID-19, achieving herd immunity depends on how many people develop protection after natural infection, how soon COVID-19 vaccines are made widely available to the general public and how many people get vaccinated. Findings have shown that herd immunity for some diseases can be achieved when about 40% of the population is vaccinated. The herd immunity threshold for COVID-19 is not yet known, but most experts estimate that 70% to 90% of Americans will need to be vaccinated for the population overall to reach herd immunity. Three COVID-19 vaccines have been authorized by the Food and Drug Administration: those produced by Pfizer-BioNTech, Moderna and Johnson & Johnson. The two-dose Pfizer and Moderna vaccines are 95% and 94% effective against symptomatic COVID-19 illness, respectively, while the single-shot Johnson & Johnson vaccine is 85% effective against severe COVID-19.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!